Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Radiosurgery × 90 days × Clear all

Sponsor

Conditions

Brain Neoplasms 24 Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 18 Lung Neoplasms 17 Neoplasm Metastasis 11 Carcinoma, Hepatocellular 8 Melanoma 6 Breast Neoplasms 6 Small Cell Lung Carcinoma 5 Pancreatic Neoplasms 5 Carcinoma, Renal Cell 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 3 Liver Neoplasms 3 Urinary Bladder Neoplasms 2 NSCLC 2 Kidney Neoplasms 2 Adenocarcinoma 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Unresectable Locally Recurrent Rectal Cancer 1 Triple Negative Breast Neoplasms 1 Thoracic Neoplasms 1 Stage II Prostate Adenocarcinoma AJCC v7 1 Spinal Cord Neoplasms 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Recurrent Head and Neck Carcinoma 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡